While HNF4α and BMAL1 are robustly co-expressed in normal hepatocytes, of significance is the distinct downregulation of BMAL1, which has been demonstrated to play tumor suppressive roles14,57,58 in HNF4α-positive HCC. The gene discussed is HNF4A; the disease is hepatocellular carcinoma.